HEADER RNA BINDING PROTEIN 07-AUG-23 8Q4T TITLE CRYSTAL STRUCTURE OF YTHDC1 IN COMPLEX WITH COMPOUND 31 (ZA_400) COMPND MOL_ID: 1; COMPND 2 MOLECULE: YTH DOMAIN-CONTAINING PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SPLICING FACTOR YT521,YT521-B; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YTHDC1, KIAA1966, YT521; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS YTHDC1, INHIBITOR, COMPLEX, READER, RNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.K.BEDI,F.ZALESAK,A.CAFLISCH REVDAT 1 06-DEC-23 8Q4T 0 JRNL AUTH R.K.BEDI,F.ZALESAK,A.CAFLISCH JRNL TITL CRYSTAL STRUCTURE OF YTHDC1 IN COMPLEX WITH COMPOUND 31 JRNL TITL 2 (ZA_400) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 50698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.7700 - 3.9500 0.97 2726 144 0.1702 0.1707 REMARK 3 2 3.9500 - 3.1400 0.93 2554 134 0.1813 0.2268 REMARK 3 3 3.1400 - 2.7400 0.97 2681 141 0.2160 0.2466 REMARK 3 4 2.7400 - 2.4900 0.97 2657 140 0.2205 0.2774 REMARK 3 5 2.4900 - 2.3100 0.99 2740 144 0.2157 0.2351 REMARK 3 6 2.3100 - 2.1800 0.99 2725 143 0.2247 0.2578 REMARK 3 7 2.1800 - 2.0700 0.99 2748 145 0.2320 0.2922 REMARK 3 8 2.0700 - 1.9800 0.99 2698 142 0.2386 0.2890 REMARK 3 9 1.9800 - 1.9000 0.93 2546 134 0.2386 0.2835 REMARK 3 10 1.9000 - 1.8400 0.98 2693 142 0.2478 0.2933 REMARK 3 11 1.8400 - 1.7800 0.98 2674 140 0.2685 0.3226 REMARK 3 12 1.7800 - 1.7300 0.98 2695 143 0.2762 0.3147 REMARK 3 13 1.7300 - 1.6800 0.98 2692 141 0.3010 0.3504 REMARK 3 14 1.6800 - 1.6400 0.98 2729 142 0.3076 0.3681 REMARK 3 15 1.6400 - 1.6000 0.99 2650 140 0.3037 0.3029 REMARK 3 16 1.6000 - 1.5700 0.98 2735 144 0.3197 0.3285 REMARK 3 17 1.5700 - 1.5400 0.99 2709 141 0.3453 0.3741 REMARK 3 18 1.5400 - 1.5100 0.91 2513 133 0.3828 0.3825 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.223 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.33 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2679 REMARK 3 ANGLE : 0.813 3648 REMARK 3 CHIRALITY : 0.054 392 REMARK 3 PLANARITY : 0.006 451 REMARK 3 DIHEDRAL : 13.608 926 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8Q4T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292132589. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50799 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.510 REMARK 200 RESOLUTION RANGE LOW (A) : 38.774 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.450 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 0.2M AMMONIUM SULPHATE, REMARK 280 0.1M BIS-TRIS PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 52.04000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 508 REMARK 465 HIS A 509 REMARK 465 ARG B 508 REMARK 465 HIS B 509 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 361 CE NZ REMARK 470 LYS A 374 CD CE NZ REMARK 470 LYS A 385 CE NZ REMARK 470 ARG A 395 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 404 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 405 CD OE1 OE2 REMARK 470 MET A 434 CG SD CE REMARK 470 SER A 435 OG REMARK 470 LYS A 437 CG CD CE NZ REMARK 470 MET A 438 CG SD CE REMARK 470 LYS A 457 CD CE NZ REMARK 470 ARG A 475 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 483 CG CD OE1 OE2 REMARK 470 ASP B 354 CG OD1 OD2 REMARK 470 LYS B 385 CG CD CE NZ REMARK 470 LYS B 386 CG CD CE NZ REMARK 470 ARG B 392 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 395 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 405 CG CD OE1 OE2 REMARK 470 SER B 424 OG REMARK 470 MET B 434 CG SD CE REMARK 470 SER B 435 OG REMARK 470 LYS B 437 CG CD CE NZ REMARK 470 ARG B 475 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 502 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 452 O HOH B 701 2.02 REMARK 500 REMARK 500 REMARK: NULL DBREF 8Q4T A 345 509 UNP Q96MU7 YTDC1_HUMAN 345 509 DBREF 8Q4T B 345 509 UNP Q96MU7 YTDC1_HUMAN 345 509 SEQADV 8Q4T GLY A 344 UNP Q96MU7 EXPRESSION TAG SEQADV 8Q4T GLY B 344 UNP Q96MU7 EXPRESSION TAG SEQRES 1 A 166 GLY THR SER LYS LEU LYS TYR VAL LEU GLN ASP ALA ARG SEQRES 2 A 166 PHE PHE LEU ILE LYS SER ASN ASN HIS GLU ASN VAL SER SEQRES 3 A 166 LEU ALA LYS ALA LYS GLY VAL TRP SER THR LEU PRO VAL SEQRES 4 A 166 ASN GLU LYS LYS LEU ASN LEU ALA PHE ARG SER ALA ARG SEQRES 5 A 166 SER VAL ILE LEU ILE PHE SER VAL ARG GLU SER GLY LYS SEQRES 6 A 166 PHE GLN GLY PHE ALA ARG LEU SER SER GLU SER HIS HIS SEQRES 7 A 166 GLY GLY SER PRO ILE HIS TRP VAL LEU PRO ALA GLY MET SEQRES 8 A 166 SER ALA LYS MET LEU GLY GLY VAL PHE LYS ILE ASP TRP SEQRES 9 A 166 ILE CYS ARG ARG GLU LEU PRO PHE THR LYS SER ALA HIS SEQRES 10 A 166 LEU THR ASN PRO TRP ASN GLU HIS LYS PRO VAL LYS ILE SEQRES 11 A 166 GLY ARG ASP GLY GLN GLU ILE GLU LEU GLU CYS GLY THR SEQRES 12 A 166 GLN LEU CYS LEU LEU PHE PRO PRO ASP GLU SER ILE ASP SEQRES 13 A 166 LEU TYR GLN VAL ILE HIS LYS MET ARG HIS SEQRES 1 B 166 GLY THR SER LYS LEU LYS TYR VAL LEU GLN ASP ALA ARG SEQRES 2 B 166 PHE PHE LEU ILE LYS SER ASN ASN HIS GLU ASN VAL SER SEQRES 3 B 166 LEU ALA LYS ALA LYS GLY VAL TRP SER THR LEU PRO VAL SEQRES 4 B 166 ASN GLU LYS LYS LEU ASN LEU ALA PHE ARG SER ALA ARG SEQRES 5 B 166 SER VAL ILE LEU ILE PHE SER VAL ARG GLU SER GLY LYS SEQRES 6 B 166 PHE GLN GLY PHE ALA ARG LEU SER SER GLU SER HIS HIS SEQRES 7 B 166 GLY GLY SER PRO ILE HIS TRP VAL LEU PRO ALA GLY MET SEQRES 8 B 166 SER ALA LYS MET LEU GLY GLY VAL PHE LYS ILE ASP TRP SEQRES 9 B 166 ILE CYS ARG ARG GLU LEU PRO PHE THR LYS SER ALA HIS SEQRES 10 B 166 LEU THR ASN PRO TRP ASN GLU HIS LYS PRO VAL LYS ILE SEQRES 11 B 166 GLY ARG ASP GLY GLN GLU ILE GLU LEU GLU CYS GLY THR SEQRES 12 B 166 GLN LEU CYS LEU LEU PHE PRO PRO ASP GLU SER ILE ASP SEQRES 13 B 166 LEU TYR GLN VAL ILE HIS LYS MET ARG HIS HET JBD A 601 25 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET JBD B 601 25 HET SO4 B 602 5 HET SO4 B 603 5 HET SO4 B 604 5 HET SO4 B 605 5 HETNAM JBD ~{N}-[4-CHLORANYL-2-[[2-CHLORANYL-6-(METHYLAMINO)PURIN- HETNAM 2 JBD 9-YL]METHYL]PHENYL]METHANESULFONAMIDE HETNAM SO4 SULFATE ION FORMUL 3 JBD 2(C14 H14 CL2 N6 O2 S) FORMUL 4 SO4 8(O4 S 2-) FORMUL 13 HOH *205(H2 O) HELIX 1 AA1 THR A 345 GLN A 353 1 9 HELIX 2 AA2 ASN A 364 GLY A 375 1 12 HELIX 3 AA3 LEU A 380 ALA A 394 1 15 HELIX 4 AA4 THR A 456 ALA A 459 5 4 HELIX 5 AA5 ASN A 463 GLU A 467 5 5 HELIX 6 AA6 GLU A 481 PHE A 492 1 12 HELIX 7 AA7 ASP A 499 MET A 507 1 9 HELIX 8 AA8 THR B 345 GLN B 353 1 9 HELIX 9 AA9 ASN B 364 GLY B 375 1 12 HELIX 10 AB1 LEU B 380 ALA B 394 1 15 HELIX 11 AB2 SER B 435 GLY B 440 5 6 HELIX 12 AB3 THR B 456 ALA B 459 5 4 HELIX 13 AB4 ASN B 463 GLU B 467 5 5 HELIX 14 AB5 GLU B 481 PHE B 492 1 12 HELIX 15 AB6 LEU B 500 MET B 507 1 8 SHEET 1 AA1 6 VAL A 376 TRP A 377 0 SHEET 2 AA1 6 PHE A 443 CYS A 449 -1 O PHE A 443 N TRP A 377 SHEET 3 AA1 6 GLY A 411 LEU A 415 -1 N ARG A 414 O ASP A 446 SHEET 4 AA1 6 VAL A 397 VAL A 403 -1 N LEU A 399 O ALA A 413 SHEET 5 AA1 6 ARG A 356 SER A 362 1 N ARG A 356 O ILE A 398 SHEET 6 AA1 6 GLU A 479 ILE A 480 -1 O ILE A 480 N PHE A 357 SHEET 1 AA2 2 LYS A 408 PHE A 409 0 SHEET 2 AA2 2 LEU A 453 PRO A 454 -1 O LEU A 453 N PHE A 409 SHEET 1 AA3 6 VAL B 376 TRP B 377 0 SHEET 2 AA3 6 PHE B 443 CYS B 449 -1 O PHE B 443 N TRP B 377 SHEET 3 AA3 6 GLY B 411 LEU B 415 -1 N ARG B 414 O ASP B 446 SHEET 4 AA3 6 SER B 396 VAL B 403 -1 N LEU B 399 O ALA B 413 SHEET 5 AA3 6 ALA B 355 SER B 362 1 N ARG B 356 O ILE B 398 SHEET 6 AA3 6 GLU B 479 ILE B 480 -1 O ILE B 480 N PHE B 357 SHEET 1 AA4 2 LYS B 408 PHE B 409 0 SHEET 2 AA4 2 LEU B 453 PRO B 454 -1 O LEU B 453 N PHE B 409 CRYST1 40.130 104.080 41.990 90.00 104.94 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024919 0.000000 0.006649 0.00000 SCALE2 0.000000 0.009608 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024648 0.00000